Clofibrate cholesterol lowering intervention  

Athromidin - Miskleron - Miscleron - Atromid S - Atromid - Ethyl Chlorophenoxyisobutyrate      

Select             pdf
Trial Studied trt Control trt patientstagsROB Trial resultAll cause deathCoronary death

cardiovascular prevention  

WHO clofibrate, 1978   clofibrateplaceboLow risk of bias suggesting 27%12%
CDP Clofibrate, 1975   clofibrateplaceboLow risk of bias suggesting -2%-15%
Scottish, 1971   clofibrateplaceboLow risk of bias negative-2%2%
Newcastle, 1971   clofibrateplaceboLow risk of bias suggesting-37%-41%
Harrold, 1969   clofibrateplacebo type 2 diabetes Low risk of bias -
Begg, 1971   clofibrateplacebosecondary preventionExploratory negative-58%-54%
Acheson, 1972   clofibrateplacebosecondary prevention cerebral vascular disease Exploratory -
VA Neurology Section, 1974   clofibrateplaceboLow risk of bias -
Cullen, 1974   clofibrateplaceboLow risk of bias -
Hanefeld, 1991   clofibrateplacebo type 2 diabetes Low risk of bias negative
SCOR, 1990     colestipol+clofibrateplacebodiabeticLow risk of bias negative-100%